Clinical trial
Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in…
NCT00215501 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00215501 |
|---|---|
| Title | Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies |
| Official title | A Phase I Trial of Capecitabine or Continuous Infusion 5-Fluorouracil in Combination With Weekly Irinotecan and Cisplatin in Patients With Advanced Solid Tumor Malignancies |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Brigham and Women's Hospital Massachusetts General Hospital |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Solid Tumor |
| Intervention type | Drug |
| Interventions | Capecitabine, 5-Fluorouracil (5-FU), Irinotecan, Cisplatin |
| Enrollment | 54 |
| Start date | Nov 1, 2001 |
| Primary completion | Sep 1, 2005 |
| Completion | Sep 1, 2008 |
| First posted | Sep 22, 2005 |
| Last update posted | Nov 2, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: